Metformin HCL 1000MG Prolonged Release Tablets IP – Matulon 1000 SR Tablets

Matulon 1000 SR Tablets
Composition:- Metformin HCl 1000mg Sustained Release

Matulon 1000 SR Tablets – Metformin HCL 1000MG Prolonged Release Tablets IP belongs to a group of anti-diabetic medicines called biguanides, which is the first-line therapy often fails to maintain adequate glycemic level and helps to prevent hepatic glucogenesis and glycogenolysis, which increases liver and peripheral tissue sensitivity to glucose and lowers Hb1Ac levels.
Its sustained-release formulation ensures gradual absorption, reducing peak plasma levels and minimizing gastrointestinal discomfort.
It is widely used as a cornerstone therapy for type 2 diabetes and is beneficial in managing metabolic syndrome and insulin resistance.

Key Points of Metformin HCL 1000MG Prolonged Release Tablets IP – Matulon 1000 SR Tablets
• Prolonged effect with Better Tolerability: Slow and steady release of metformin ensures fewer gastrointestinal side effects like nausea and bloating, improving patient adherence.
• First-Line Therapy for Type 2 Diabetes: Proven efficacy in glycemic control, weight neutrality, and insulin sensitivity improvement makes it a gold-standard treatment.
• Cardiovascular and Metabolic Benefits: Reduces HbA1c levels, supports weight management, and offers potential cardiovascular protective effects.

Can be Prescribed by:
• Endocrinologists
• Diabetologists
• General Physicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.